Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
The British Journal of Dermatology
|
March 3, 2021
Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort
M A El Sharouni, A H R Varey, A J Witkamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 30, 2020
Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor
M-A El Sharouni, M D Stodell, T Ahmed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma
A M Menzies, S N Lo, R P M Saw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2021
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
C N Owen, X Bai, T Quah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2021
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
R V Rawson, C Adhikari, C Bierman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
F Dimitriou, K Namikawa, I L M Reijers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma
P Grover, S N Lo, I Li, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
The British Journal of Dermatology
|
March 3, 2021
Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort
M A El Sharouni, A H R Varey, A J Witkamp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 30, 2020
Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor
M-A El Sharouni, M D Stodell, T Ahmed, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma
A M Menzies, S N Lo, R P M Saw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2021
Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma
C N Owen, X Bai, T Quah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2021
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
R V Rawson, C Adhikari, C Bierman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 18, 2022
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
F Dimitriou, K Namikawa, I L M Reijers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma
P Grover, S N Lo, I Li, et al.
Page
of 2